114 related articles for article (PubMed ID: 1892370)
1. The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys.
Kurlan R; Kim MH; Gash DM
Ann Neurol; 1991 Jun; 29(6):677-9. PubMed ID: 1892370
[TBL] [Abstract][Full Text] [Related]
2. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism.
Kurlan R; Kim MH; Gash DM
Mov Disord; 1991; 6(2):111-8. PubMed ID: 2057003
[TBL] [Abstract][Full Text] [Related]
3. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
[TBL] [Abstract][Full Text] [Related]
4. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
[TBL] [Abstract][Full Text] [Related]
5. Hemiparkinsonism in monkeys following unilateral common carotid artery infusion of MPTP. A study of behavior, biochemistry and histology.
Chen SD; Zhou XD; Xu DL; Li GW; Tang QM; Xu XR
Chin Med J (Engl); 1991 Sep; 104(9):758-63. PubMed ID: 1935358
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of the immunophilin ligand GPI 1046 in MPTP-treated monkeys.
Emborg ME; Shin P; Roitberg B; Sramek JG; Chu Y; Stebbins GT; Hamilton JS; Suzdak PD; Steiner JP; Kordower JH
Exp Neurol; 2001 Mar; 168(1):171-82. PubMed ID: 11170732
[TBL] [Abstract][Full Text] [Related]
7. Basal ganglia lesions after MPTP administration in rhesus monkeys.
Emborg ME; Moirano J; Schafernak KT; Moirano M; Evans M; Konecny T; Roitberg B; Ambarish P; Mangubat E; Ma Y; Eidelberg D; Holden J; Kordower JH; Leestma JE
Neurobiol Dis; 2006 Aug; 23(2):281-9. PubMed ID: 16766201
[TBL] [Abstract][Full Text] [Related]
8. Developing a stable bilateral model of parkinsonism in rhesus monkeys.
Smith RD; Zhang Z; Kurlan R; McDermott M; Gash DM
Neuroscience; 1993 Jan; 52(1):7-16. PubMed ID: 8433810
[TBL] [Abstract][Full Text] [Related]
9. [Spontaneous saccades in MPTP-induced hemi-parkinsonian monkeys].
Usui S; Fukuda H; Hikosaka O
Rinsho Shinkeigaku; 1990 Nov; 30(11):1181-9. PubMed ID: 2085922
[TBL] [Abstract][Full Text] [Related]
10. Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates.
Wichmann T; Kliem MA; DeLong MR
Exp Neurol; 2001 Feb; 167(2):410-24. PubMed ID: 11161630
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.
Goldstein DS; Li ST; Holmes C; Bankiewicz K
J Pharmacol Exp Ther; 2003 Sep; 306(3):855-60. PubMed ID: 12805479
[TBL] [Abstract][Full Text] [Related]
12. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
Doudet D; Gross C; Lebrun-Grandié P; Bioulac B
C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601
[TBL] [Abstract][Full Text] [Related]
13. [Intrathecal infusion of brain-derived neurotrophic factor protects nigral dopaminergic neurons from degenerative changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced monkey parkinsonian model].
Takeda M
Hokkaido Igaku Zasshi; 1995 Nov; 70(6):829-38. PubMed ID: 8582706
[TBL] [Abstract][Full Text] [Related]
14. 6-[18F]fluoro-L-dopa and cerebral blood flow in unilaterally MPTP-treated monkeys.
Doudet DJ; Wyatt RJ; Cannon-Spoor E; Suddath R; McLellan CA; Cohen RM
J Neural Transplant Plast; 1993; 4(1):27-38. PubMed ID: 7509198
[TBL] [Abstract][Full Text] [Related]
15. [Experimental research on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian animal models in the rhesus monkey and C57 black mouse].
Chen S
Zhonghua Yi Xue Za Zhi; 1990 May; 70(5):252-4, 18. PubMed ID: 2168792
[TBL] [Abstract][Full Text] [Related]
16. MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose.
Emborg-Knott ME; Domino EF
Exp Neurol; 1998 Aug; 152(2):214-20. PubMed ID: 9710520
[TBL] [Abstract][Full Text] [Related]
17. Lesions in monkey globus pallidus externus exacerbate parkinsonian symptoms.
Zhang J; Russo GS; Mewes K; Rye DB; Vitek JL
Exp Neurol; 2006 Jun; 199(2):446-53. PubMed ID: 16487515
[TBL] [Abstract][Full Text] [Related]
18. Effects of pramipexole on contraversive rotation and functional motor impairments in 1-methyl-4-phenyl1,2,3, 6-tetrahydropyridine-induced chronic hemiparkinsonian monkeys.
Domino EF; Ni L; Zhang H; Kohno Y; Sasa M
J Pharmacol Exp Ther; 1998 Dec; 287(3):983-7. PubMed ID: 9864283
[TBL] [Abstract][Full Text] [Related]
19. Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys.
Lieu CA; Deogaonkar M; Bakay RA; Subramanian T
Parkinsonism Relat Disord; 2011 Jan; 17(1):34-9. PubMed ID: 21074478
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and biochemical parameters of parkinsonism induced by 1-methyl-4-phenyl-1,2,2,6-tetrahydropyridine and its methyl-phenyl and methoxy-phenyl derivatives in C57Bl/6 mice].
Lermontova NN; Soliakov LS; Bachurin SO; Serkova TP; Petrova LN; Dranyĭ OA; Tkachenko SE; Kalashnikov VV
Biull Eksp Biol Med; 1990 Oct; 110(10):397-9. PubMed ID: 2279092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
